Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% StakeTradingView·Jul 24 at 03:36 PMNIKI+15.96%APM0.00%
Niki BioSolutions falls 9% as gains fade after gene testing dealUS Stock Market Update·Jul 23 at 02:10 PMNIKI+15.96%
Niki BioSolutions falls 5% as early 44% surge fadesUS Stock Market Update·Jul 23 at 12:32 PMNIKI+15.96%
Niki BioSolutions climbs 2% on APOE testing deal after 44% premarket surgeUS Stock Market Update·Jul 23 at 09:00 AMNIKI+15.96%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC+39.24%HYFT+3.85%
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.benzinga_article·Jul 23 at 07:04 AMNIKI+15.96%
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)Unusual Whales·Jul 23 at 07:03 AMNIKI+15.96%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 12:05 PMTELO+3.31%CPHI+8.33%
The Market's Misfits: Who is Faking It and Who is Building the Future?Global Report·Jul 21 at 04:13 AMCSIQ+7.58%AVEX+10.79%
Aptorum Group Provides Update on DiamiR Biosciences Merger | APM Stock NewsStockTitan·Jul 16 at 02:00 AMAPM0.00%NIKI+15.96%
Aptorum, DiamiR set to close all-stock merger before fiscal 2027, rebrand as Niki BioSolutionsPUBT·Jul 8 at 07:04 AMAPM0.00%NIKI+15.96%
Aptorum amends 6-K to extend DiamiR merger termination date to July 31, 2026PUBT·Jun 22 at 04:01 PMAPM0.00%NIKI+15.96%
Aptorum announces DiamiR-AlzLabs collaboration on blood-based Alzheimer’s biomarkersPUBT·Jun 22 at 07:03 AMAPM0.00%NIKI+15.96%
Pre-market hot trades in US stocks: Aptorum up 14.85% pre-market; Veru down 14.41% pre-marketPrice Alert·Jun 8 at 04:12 AMAPM0.00%VERU+0.45%